ALQ Share Price Performance
AU$0
-15.59 (-100.00%)
Price AU$0
Fair ValueAU$22.47
Share Pricen/a
We Think ALS (ASX:ALQ) Can Stay On Top Of Its Debt
Jan 07
ALS Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
ALQ Community Narratives
AN
Fair Value AU$22.47 4.2% overvalued intrinsic discount
ALQ: Anticipate Limited Upside as Margins and Revenue Will Modestly Improve
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AN
Fair Value AU$12.84 82.3% overvalued intrinsic discount
Rising ESG Requirements And Automation Will Erode Testing Demand
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value AU$26 9.9% undervalued intrinsic discount
Electrification And Renewable Energy Trends Will Expand Testing Capacity
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Electrification And Renewable Energy Trends Will Expand Testing Capacity
Key Takeaways Accelerated integration of key acquisitions, major lab investments, and automation are driving early margin improvement, recurring revenues, and strong global market positioning. Industry consolidation, robust demand for critical minerals, and selective high-growth acquisitions are fueling above-expectation revenue growth and long-term margin expansion.Read more
6
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AU$26
9.9% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
8.76% p.a.
Profit Margin
13.82%
Future PE
30.52x
Price in 2029
AU$31.88
ALQ: Anticipate Limited Upside as Margins and Revenue Will Modestly Improve
Key Takeaways Integration and optimization of acquisitions could improve operational efficiency, enhancing margins and earnings over time. Expertise in PFAS testing positions ALS to capitalize on regulatory trends, potentially boosting revenue and margins in Life Sciences.Read more
129
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AN
AU$22.47
4.2% overvalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
7.13% p.a.
Profit Margin
12.51%
Future PE
30.48x
Price in 2028
AU$27.56
Rising ESG Requirements And Automation Will Erode Testing Demand
Key Takeaways Rising automation and self-sufficiency in client industries threaten ALS's core revenues, requiring expensive technological upgrades and risking declining margins. Exposure to mining cycles, tighter regulations, and intensifying competition jeopardize growth prospects and could further squeeze profitability and operational efficiency.Read more
8
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AU$12.84
82.3% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
6.28% p.a.
Profit Margin
12.13%
Future PE
18.37x
Price in 2028
AU$16.45
Trending Discussion
Recently Updated Narratives
AN
ALQ: Raised FY26 Guidance And Dividend Will Support Stronger Future Returns
Fair Value: AU$26 9.9% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ALQ: Future Dividend And Margin Trends Will Support Measured Outlook
Fair Value: AU$22.47 4.2% overvalued intrinsic discount
11 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising ESG Requirements And Automation Will Erode Testing Demand
Fair Value: AU$12.84 82.3% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
ALS Limited Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
May 26, 2026
- 0.53
- 29.30%
- 8.49%
- 80.9%
About ALQ
- Founded
- 1863
- Employees
- 20515
- CEO
- WebsiteView website
ALS Limited engages in the provision of professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation services, tribology testing services, and related analytical testing. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.
